Aveir
Device Cardiac Rhythm Management
PDI 05415067034847
General payments
$3,984,861
Research payments
$4,545,995
Through program year 2025, $3,984,861 in general payments and $4,545,995 in research payments were reported against Aveir (Cardiac Rhythm Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $91,355 | 13 |
| 2024 | General | $1,883,343 | 13,908 |
| 2024 | Research | $180,532 | 98 |
| 2023 | General | $2,101,418 | 14,375 |
| 2023 | Research | $4,274,108 | 889 |
| 2022 | General | $99 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 95 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
28,284 general · 1,000 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.